Genetics of PICALM expression and Alzheimer's disease

• Published in: PloS one 2014-03, Vol.9 (3), p.e91242-e91242
• Main Authors: Parikh, Ishita, Fardo, David W, Estus, Steven
• Format: Article
• Language: English
• Subjects: Advertising executives; Aged; Aged, 80 and over; Aging; Alleles; Alternative Splicing; Alzheimer Disease - genetics; Alzheimer Disease - metabolism; Alzheimer Disease - pathology; Alzheimer's disease; Analysis; Autopsy; Biology; Brain; Brain - metabolism; Brain - pathology; Cloning; Endocytosis; Female; Gene Expression; Genes; Genetic aspects; Genetic engineering; Genetic research; Genome-wide association studies; Genomes; Genomics; Health aspects; Humans; Immunohistochemistry; Leukemia; Male; Medicine; Monomeric Clathrin Assembly Proteins - genetics; Monomeric Clathrin Assembly Proteins - metabolism; Neuropathology; Older people; Physiology; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Protein Isoforms; Proteins; Risk factors; RNA; Target marketing
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0091242

Novel Alzheimer's disease (AD) risk factors have been identified by genome-wide association studies. Elucidating the mechanism underlying these factors is critical to the validation process and, by identifying rate-limiting steps in AD risk, may yield novel therapeutic targets. Here, we evaluated the association between the AD-associated polymorphism rs3851179 near PICALM, which encodes a clathrin-coated pit accessory protein. Immunostaining established that PICALM is expressed predominately in microvessels in human brain. Consistent with this finding, PICALM mRNA expression correlated with expression of the endothelial genes vWF and CD31. Additionally, we found that PICALM expression was modestly increased with the rs3851179A AD-protective allele. Analysis of PICALM isoforms found several isoforms lacking exons encoding elements previously identified as critical to PICALM function. Increased expression of the common isoform lacking exon 13 was also associated with the rs3851179A protective allele; this association was not apparent when this isoform was compared with total PICALM expression, indicating that the SNP is associated with total PICALM expression and not this isoform per se. Interestingly, PICALM lacking exons 2-4 was not associated with rs3851179 but was associated with rs592297, which is located in exon 5. Thus, our primary findings are that multiple PICALM isoforms are expressed in the human brain, that PICALM is robustly expressed in microvessels, and that expression of total PICALM is modestly correlated with the AD-associated SNP rs3851179. We interpret these results as suggesting that increased PICALM expression in the microvasculature may reduce AD risk.